52
Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont.,

Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Embed Size (px)

Citation preview

Page 1: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Cardiovascular Anatomy, Physiology and Pharmacology

BS913

Lecture 10: Pharmacology cont., …

Page 2: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Drugs used to treat cardiac conditions:

Page 3: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Common drugs administered to cardiac patients

- Nitrates

- ß-blockers

- ACE inhibitors

- Digoxin

- Diuretics

- Anti-arrhythmics

- Ca-ch. blockers

- Aspirin

- Warfarin

- Statins

- others

Page 4: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Today

- Arrhythmias

- Anti-platelets / Anti-coagulants

- Hyperlipidaemia

- Implications for exercise

Page 5: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Arrhythmia

- Heart rhythm normally generated by pacemaker cells in SA node

- Heart rhythm is affected by both NA and ACh, released from sympathetic and parasympathetic nerves

Page 6: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …
Page 7: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Arrhythmia

- Heart rhythm can be disturbed in a variety of ways, producing anything

- From occasional discomfort

- To symptoms of heart failure

- Arrhythmias can occur in the apparently healthy heart

- Serious arrhythmias are usually associated with heart disease

Page 8: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Arrhythmia

- Supraventricular Arrhythmias arise in atrial myocardium or AV node

- Ventricular arrhythmias originate in ventricles

Page 9: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Arrhythmia

- May be caused by an ectopic focus, which starts firing at a higher rate than SA node

- More commonly they are caused by a re-entry mechanism:

- AP delayed for some pathological reason, re-invade nearby muscle fibres, which again depolarize (loop of depolarization)

Page 10: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …
Page 11: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …
Page 12: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

What are possibilities of drug action in order to treat arrhythmia?

Try to find three different mechanisms

Page 13: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …
Page 14: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Treatment of ventricular and supraventricular arrhythmias- Class I A agents

- e.g. Disopyramide- act by voltage-dependent (open)

Na+ channels

- act on atrial and ventricular muscle cells, AV node and Purkinje fibres

- slow phase 4, raise threshold of phase 0 and slow phase 0 of the AP

Page 15: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Treatment of ventricular and supraventricular arrhythmias- Class III agents

- e.g. Amiodarone- act by slowing repolarization

(phase 3)- Prolongs effective refractory period,

especially of Purkinje fibers and ventricular muscle cells

- Last choice medication because of adverse effects (photo-sensitivity, liver damage etc.

Page 16: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Treatment of ventricular arrhythmias- Class I B agents

- e.g. Lignocaine- act by blocking (inactive)

voltage dependent Na+ channels- Given intravenously- first-line drug in treatment of ventricular arrhythmias after MI- In ischaemic areas many Na+ channels are inactivated and therefore susceptible to lignocaine

Page 17: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Treatment of supraventricular arrhythmias

- Class IV agents- e.g. Verapamil, Digitalis- act by blocking Ca++ channels

- Verapamil: - powerful effects on AVN- negative inotropic effect; may

worsen heart failure- combination with ß-blockers fatal

Page 18: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Treatment of supraventricular arrhythmias

- Digitalis: - slows conduction and prolongs

refractory period in AVN and bundle of His

- used in atrial fibrillation (does not stop it)

- slows and strengthens ventricular beat

Page 19: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Alternatives to drugs in treatment of arrhythmias

- Pacemakers

Page 20: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Why do so many cardiac patients take anti-platelet and anti-coagulation drugs?

Page 21: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …
Page 22: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Thrombus formation

- Thrombosis is formation of a clot

- Thrombus may form in any vessel, artery or vein, when blood flow is impeded

Page 23: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Thrombus formation

- Venous thrombosis:

- As a result of venous stasis

- Injury to vessel wall

- Altered blood coagulation

- Thrombus: Fibrin web enmeshed with platelets and red blood cells

Page 24: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Thrombus formation

- Venous thrombosis - embolism

- Deep vein thrombosis in lower extremities most common type of venous thrombosis

Page 25: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Thrombus formation

- Arterial thrombosis:

- Can occur because of atherosclerosis or arrhythmia (e.g. atrial fibrillation)

- May begin small, but fibrin, platelets and red blood cells attach increasing size and shape of thrombus

- Thrombus: mainly formed by platelet aggregation (fibrin and red blood cells)

Page 26: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Fig. 8.14 Therapeutic Approaches to Thrombosis and Embolism

Page 27: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Prevention of arterial thrombosis

- Decrease platelet aggregation (stickiness)

- Main three drugs:- Aspirin (75-150 mg)

- Clopidogrel

- Dipyridamole

- Anti-platelet drugs

Page 28: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Anti platelet drugs used in …

- Primary prevention ????

- Secondary prevention in angina and bypass surgery patients

- Secondary prevention of cerebrovascular or cardiovascular thrombosis, i.e. stroke, MI

- Early treatment of MI (acute phase)

Page 29: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Side effects of anti platelet drugs - Aspirin:

- Bronchospasm- Gastrointestinal bleeding- Other haemorrhage

- Clopidogrel: - As above but - Less gastrointestinal problems

- Dipyridamole: - Nausea / diarrhoea - Throbbing headache- hypotension

Page 30: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Prevention of venous thrombosis

- Vitamin K antagonists

- Anti-coagulants: Warfarin

- Synthesis of clotting factors X, IX, VII and II in the liver requires Vitamin K

- Clotting cascade is impaired

Page 31: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

The coagulation cascade

Page 32: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Anti-coagulants used in …

- Valve disease (e.g. mitral stenosis)

- Valve surgery

- Atrial fibrillation

- Preventing clot formation in patients with:

- Prevention of recurrence of clots forming

- Following deep vein thrombosis

- Following pulmonary embolus

Page 33: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Side effects of anti coagulants

- Warfarin: - Haemorrhage

- As result of external damage- Or internal bleeding

- State of clotting system needs to be monitored regularly

- Patients should not take Aspirin in addition

Page 34: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …
Page 35: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Lipid lowering drugs

Why are they prescribed?

Page 36: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

True or not true?

- “Using margarine instead of butter will help lower my cholesterol”

- Most people can raise their good cholesterol levels by exercising, not smoking and maintaining a healthy weight.

- 105 million Americans have a total cholesterol level of 200mg/dl (5.0 mmol/l) or higher

Page 37: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

True or not true?

- Thin people do not have to worry about high cholesterol

- The process leading to atherosclerosis can begin in children

- “Since I started taking medication for my high cholesterol, I do not need to worry about what I eat”

Page 38: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Lipid lowering drugs

- To control the levels of cholesterol and trigycerides

- Cholesterol production in the liver

- In some patients production in liver is NOT down regulated

- Production in the liver is reduced when we eat fat in the diet

Page 39: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Lipid lowering drugs- Statins:

- inhibit enzyme that catalyses a step in cholesterol synthesis

- Used for: - Reducing LDL cholesterol- Moderately reducing TG- moderately increasing HDL

- Side effects:- Gastrointestinal upsets- Muscle pain (inflammation of muscles = myositis), aching legs- headache

Page 40: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Lipid lowering drugs

- Fibrates: - Effective modulator of blood lipids

- Used for: - Mainly to decrease TG and LDL- raise HDL

- Side effects: - Gallstones- Rash- Acute pain in leg muscles if kidney function is impaired

Page 41: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Lipid lowering drugs

- Bile acid binders: - Bile acids are used for digestion - Bile acids are synthesized from cholesterol - Bile acid binder stop recycling of bile acids - More cholesterol used for synthesizing bile acid

Page 42: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Lipid lowering drugs

- Bile acid binders:

- Side effects: - Gastrointestinal upsets- Can raise TG- aching legs

- Used for: - Reducing LDL cholesterol

Page 43: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Implications for exercise

Page 44: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

ß-blocker

- Suppress HR and blood pressure response

- HR ranges to determine training intensities must base on ETT performed on medication

- Training intensity using Borg scale (and HR) – requires proper education

- Risk of postural hypotension

- Reduced CO

Page 45: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Nitrates

- Risk of postural hypotension

- Longer cool down is recommendable

- Nitrates prior to exercise can increase exercise tolerance by preventing angina

Page 46: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Calcium channel blockers

- Reduced HR response to exercise (verapamil, diltiazem)

- Possible HR increase with type 2 (e.g. Nifedipin)

Page 47: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

ACE inhibitors

- long-term increase in exercise capacity due to treatment of heart failure

- Positive effect on CO

Page 48: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Diuretics

- Aching legs

- Dehydration

- Drinks must be available during classes

- Patients need to use toilet more frequently (urgently)

Page 49: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Digoxin and Amiodarone

- Slower HR response to exercise possible

- Reduced exercise capacity due to depressant effect on myocardium

Page 50: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Cardio-vascular drugs

- May change / impair adjustment to exercise

- Risk of postural hypotension

Page 51: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

Anti-coagulants

- Possible risk of bleeding if injured

- Extra care needed when using sports equipment

Page 52: Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …

- Ask whether medicationhas changed

Before a class

- Ask how client feels

- Measure BP